Current state of home-based exercise interventions in patients with congenital heart disease: a systematic review.

cardiac rehabilitation complex congenital heart disease congenital heart disease eHealth/telemedicine/mobile health valvular heart disease

Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
03 2020
Historique:
received: 12 07 2019
revised: 28 10 2019
accepted: 04 11 2019
pubmed: 7 12 2019
medline: 23 10 2020
entrez: 7 12 2019
Statut: ppublish

Résumé

Home-based exercise training is a promising alternative to conventional supervised training for patients with congenital heart disease (CHD). Even though the beneficial effect of exercise interventions is well established in patients with CHD, knowledge concerning variety and utility of existing programmes is still lacking. Therefore, the aim of this review is to give an overview about existing home-based exercise interventions in patients with CHD. A systematic search was performed in PubMed, Cochrane, Scopus and PEDro (2008-2018) for relevant clinical trials that provided any kind of home-based exercise with patients with CHD. All articles were identified and assessed by two independent reviewers. Seven articles with 346 paediatric CHD (18 months to 16 years) and five articles with 200 adults with CHD (21-41 years) were included. Most studies performed a supervised home-based exercise intervention with children and adolescents exercising at least three times per week with duration of 45 min for 12 weeks. Reported outcome measurements were health-related quality of life and physical activity, but mostly exercise capacity measured as peak oxygen uptake that improved in four studies (1.2%, 7%, 7.7%, 15%; p<0.05), walking distance in two (3.5%, 19.5%, p<0.05,) or walking time (2 min, p=0.003) in one. The dropout rates were high (15%), and compliance to the training programme was not reported in the majority of the studies (58%). Home-based exercise interventions are safe, feasible and a useful alternative to supervised cardiac rehabilitation for all age groups of patients with CHD. Nevertheless, training compliance represents a major challenge.

Identifiants

pubmed: 31806699
pii: heartjnl-2019-315680
doi: 10.1136/heartjnl-2019-315680
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

333-341

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Michael Meyer (M)

Institute for Preventive Pediatrics, Technical University of Munich, Munich, Germany michael.meyer@tum.de.
Department of Pediatric Cardiology, German Heart Centre Munich of the Free State of Bavaria, München, Bayern, Germany.

Leon Brudy (L)

Institute for Preventive Pediatrics, Technical University of Munich, Munich, Germany.
Department of Pediatric Cardiology, German Heart Centre Munich of the Free State of Bavaria, München, Bayern, Germany.

Luisa García-Cuenllas (L)

Department of Pediatric Cardiology, Hospital Sant Joan de Déu, Barcelona, Catalunya, Spain.

Alfred Hager (A)

Department of Pediatric Cardiology, German Heart Centre Munich of the Free State of Bavaria, München, Bayern, Germany.

Peter Ewert (P)

Department of Pediatric Cardiology, German Heart Centre Munich of the Free State of Bavaria, München, Bayern, Germany.

Renate Oberhoffer (R)

Institute for Preventive Pediatrics, Technical University of Munich, Munich, Germany.
Department of Pediatric Cardiology, German Heart Centre Munich of the Free State of Bavaria, München, Bayern, Germany.

Jan Müller (J)

Institute for Preventive Pediatrics, Technical University of Munich, Munich, Germany.
Department of Pediatric Cardiology, German Heart Centre Munich of the Free State of Bavaria, München, Bayern, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH